In April 2022, Scorpius, a San Antonio-based company specializing in emerging biotech and academic research, announced it would build the plant on ...
News
- Scorpius CEO acknowledges agreement with state to build Manhattan facility is no more
- Breast Cancer: Personalized Treatments and Approaches - Born2Invest
Efforts also prioritize patients' quality of life through holistic care. GEICAM highlighted these innovations at the San Antonio Breast Cancer ...
- Treatments for neurological disorders draw PE interest: 5 deals
1. InTandem Capital-backed Vivo Infusion snaps up Neurology Institute of San Antonio and Vista Infusions. Vivo Infusion, a portfolio company of ...
- Victor Wembanyama scores 30, and Spurs roll past Pacers in Paris 140-110 - News4JAX
Victor Wembanyama scored 30 points in his first NBA game on his native French soil, Devin Vassell added 25 and the San Antonio Spurs beat the ...
- Iovance Biotherapeutics sues insurer to cover patients' clinical trial injuries - San Francisco ...
San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Peninsula biotech company sues insurance company to cover patients' ...